News und Analysen
Bargain Alert: Alphabet Stock Won’t Be This Cheap For Long
While it managed to tag a fresh all-time high in January, shares of Alphabet Inc (NASDAQ: GOOGL) have been trading softly in the weeks since. It’s a usual divergence from the broader market, given
Institutions are Buying Broadcom Stock, a 30% Discount to Nvidia
Everyone in the market is excited about the new breakouts in the technology stock space, with a particular focus on names like NVIDIA (NASDAQ: NVDA), termed the king of the pack. After breaking
Apple Scraps EV Plans: Here’s What’s Next, Lower Prices
Unsurprisingly, Apple (NASDAQ: AAPL) scrapped its plans to build an electric vehicle. After ten years of effort, the goal to launch a 100% autonomous vehicle in 2024 failed to produce even a
Biotech Hot Stock 2024: Erstklassige Studienergebnisse - Hautkrebs vollständig geheilt. Diese Biotech-Aktie jetzt kaufen nach 15.973% mit Biotech ($BNTX)
Biotech Hot Stock 2024: Erstklassige Studienergebnisse - Hautkrebs vollständig geheilt. Diese Biotech-Aktie jetzt kaufen
06.03.24 08:02
London (www.aktiencheck.de, Anzeige)
Eilt: 95% weniger Medikamente - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: 95% weniger Medikamente - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Hot Stock nach 9.290% mit Novo-Nordisk
05.03.24
London (www.aktiencheck.de, Anzeige)
Eilt: 100 mal wirksamer gegen Krebs - Großinvestoren unmittelbar vor Einstieg. Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: 100 mal wirksamer gegen Krebs - Großinvestoren unmittelbar vor Einstieg. Neuer 503% Biotech Hot Stock nach 15.973%
04.03.24 08:02
London (www.aktiencheck.de , Anzeige)
Nvidia's Soaring Success: Too Late to Buy?
At the forefront of the market surge stands Nvidia (NASDAQ: NVDA), continuing its meteoric rise into the new year. Last year’s champion stock has wasted no time in extending its winning streak,
3 Stocks Showing Constructive Pullbacks with Indexes at New Highs
One of the most exciting things for an investor or trader is to look at tier account statement, or at the charts of what they own, and see a stock like Nvidia Corp. (NASDAQ: NVDA) or even the
Zscaler Stock Price Plunges: Buy the Dip Candidate
Zscaler (NASDAQ: ZS) had a robust Q2 and raised its guidance, but it was not enough to lift the market. The results and valuation suggest the stock is priced to perfection following the
Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 503% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 503% Biotech Aktientip nach 134.452% mit Biogen
01.03.24 08:03
London (www.aktiencheck.de, Anzeige)
Salesforce.com Stock Will Set a New High This Year
Salesforce.com’s (NYSE: CRM) stock price is having trouble with traction following the Q4 results and guidance, but a massive correction is not expected for this tech stock. The results did not
bluebird bio Stock Signals Potential to be a Multi-bagger
It isn’t often that you can find the right story at the right time to give you a good chance of multiplying your wealth; these so-called multi-bagger stocks get their name because their price sees
Eilt: 100 mal wirksamer gegen Krebs - Blockbuster gegen Krebs. Massives Kaufsignal.Neuer 503% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: 100 mal wirksamer gegen Krebs - Blockbuster gegen Krebs. 503% Biotech Hot Stock nach 15.973% mit BioNTech ($BNTX)
29.02.24 08:02
London (www.aktiencheck.de , Anzeige)
How to Use Credit Spreads to Make Income from Options
If you are bullish on any optionable stock in any stock sector, you can play any number of options trades. The easiest directional strategy is to buy a call option. However, you will fight time
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Workday, Inc. (NASDAQ: WDAY) issued a lackluster FQ2 report that left the market wishing for more. However, as tepid as the results are, underperformance is relative to analysts' consensus
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 525% Biotech Hot Stock nach 9.290% mit Novo-Nordisk
28.02.24 08:03
London (www.aktiencheck.de, Anzeige)
Goldman upgraded Nvidia stock, one metric says it could go higher
Today's market seems to be all over the hype stories found in the world of technology stocks. This is especially the case with blowout performances by names like Nvidia Corporation (NASDAQ: NVDA)
bluebird bio: How to play LEAPS options for growth and income
Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG
Thinking long-term? Don't lose interest in Pinterest
Pinterest Inc. (NYSE: PINS) stock suffered a 12% sell-off on its Q4 2023 earnings report. The main reason for the selling was a miss on the top line, as revenues failed to beat consensus analyst
Salesforce stock got a boost. Is it growing off the Nvidia boom?
Most hype surrounds technology stocks, particularly after the king of the sector, Nvidia Corp. (NASDAQ: NVDA), kept breaking past all-time high prices on ever-increasing financial expansion. There
Eilt: Durchbruch in der Krebsforschung - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Durchbruch in der Krebsforschung - 100 mal wirksamer gegen Krebs. 525% Biotech Aktientip nach 15.973% mit BioNTech
27.02.24
London (www.aktiencheck.de, Anzeige)
Is The Trade Desk signaling the rebound of digital advertising?
The Trade Desk Inc. (NASDAQ: TTD) is a leading independent programmatic advertising technology (AdTech) platform provider. Its demand-side platform (DSP) allows companies to automate their digital
Is CRISPR Therapeutics the NVIDIA of gene editing?
CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approval for a gene-editing therapy for
Analysts boosted Snowflake stock, big firms are buying now
All the market hype is now focusing on the world of technology stocks, especially after the massive run-up in names like Nvidia Corporation (NASDAQ: NVDA) and other companies involved with the
Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)
26.02.24
London (www.aktiencheck.de, Anzeige)
Link